JP2015503918A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015503918A5 JP2015503918A5 JP2014550544A JP2014550544A JP2015503918A5 JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5 JP 2014550544 A JP2014550544 A JP 2014550544A JP 2014550544 A JP2014550544 A JP 2014550544A JP 2015503918 A5 JP2015503918 A5 JP 2015503918A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international
- cell
- january
- literature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161582070P | 2011-12-30 | 2011-12-30 | |
| US61/582,070 | 2011-12-30 | ||
| US201261591211P | 2012-01-26 | 2012-01-26 | |
| US61/591,211 | 2012-01-26 | ||
| PCT/US2012/072331 WO2013102219A1 (en) | 2011-12-30 | 2012-12-31 | Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015503918A JP2015503918A (ja) | 2015-02-05 |
| JP2015503918A5 true JP2015503918A5 (enExample) | 2016-02-18 |
| JP6548897B2 JP6548897B2 (ja) | 2019-07-24 |
Family
ID=48698707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014550544A Active JP6548897B2 (ja) | 2011-12-30 | 2012-12-31 | 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用 |
Country Status (12)
| Country | Link |
|---|---|
| US (7) | US9803176B2 (enExample) |
| EP (2) | EP2798058B1 (enExample) |
| JP (1) | JP6548897B2 (enExample) |
| CA (2) | CA3113484A1 (enExample) |
| DK (1) | DK3321355T3 (enExample) |
| ES (2) | ES2890126T3 (enExample) |
| HR (1) | HRP20211373T1 (enExample) |
| HU (1) | HUE056817T2 (enExample) |
| PL (1) | PL3321355T3 (enExample) |
| PT (1) | PT3321355T (enExample) |
| SI (1) | SI3321355T1 (enExample) |
| WO (1) | WO2013102219A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2623940C (en) | 2005-09-27 | 2017-01-10 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| US9526770B2 (en) | 2011-04-28 | 2016-12-27 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| CA2837878A1 (en) | 2011-06-10 | 2012-12-13 | Tissuetech, Inc. | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
| JP6343671B2 (ja) * | 2013-12-12 | 2018-06-13 | サムスン ライフ パブリック ウェルフェア ファウンデーション | トロンビンを利用した幹細胞由来のエキソソームの生成促進方法 |
| US9919011B2 (en) | 2014-03-18 | 2018-03-20 | Samsung Life Public Welfare Foundation | Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome |
| AU2015264025A1 (en) * | 2014-05-21 | 2016-12-01 | Mimedx Group, Inc. | Micronized Wharton's jelly |
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| EP3167049A4 (en) | 2014-07-08 | 2017-11-29 | MIMEDX Group Inc. | Micronized wharton's jelly |
| WO2016138025A2 (en) | 2015-02-23 | 2016-09-01 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| JP2018516869A (ja) | 2015-05-20 | 2018-06-28 | ティッシュテック，インク． | 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法 |
| KR20170020273A (ko) | 2015-08-12 | 2017-02-22 | (주)차바이오텍 | 향상된 탯줄 유래 부착형 줄기세포, 그의 제조방법 및 용도 |
| TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
| EP3474869B1 (en) * | 2016-06-24 | 2025-04-09 | Osiris Therapeutics, Inc. | Human tissue derived compositions and uses thereof |
| KR102048228B1 (ko) | 2016-12-02 | 2019-11-25 | 가톨릭대학교 산학협력단 | Ｔ 세포 자극용 엑소좀 및 이의 약제학적 용도 |
| KR101864234B1 (ko) * | 2017-07-04 | 2018-06-04 | 인하대학교 산학협력단 | 음경해면체 유래 엑소좀을 유효성분으로 포함하는, 발기부전 예방, 개선 또는 치료용 조성물 |
| US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
| CN108239621B (zh) * | 2018-01-24 | 2020-08-18 | 北京臻溪谷医学研究中心（有限合伙） | 一种胎盘亚全能干细胞分离、扩增、冻存、复苏干细胞的方法 |
| US20230357724A1 (en) | 2019-01-16 | 2023-11-09 | University Of Utah Research Foundation | Human umbilical cord mesenchymal stem cell sheets and methods for their production |
| EP3911734A4 (en) * | 2019-01-16 | 2022-11-09 | University of Utah Research Foundation | USING MESENCHYMATOUS STEM CELL SHEETS TO PREVENT UTERINE SCARS |
| US20230338428A1 (en) * | 2020-09-08 | 2023-10-26 | Amit Patel | Allogenic umbilical cord stem cells for treating severe respiratory conditions |
| US20230057957A1 (en) * | 2021-08-23 | 2023-02-23 | Therapeutic Solutions International, Inc. | Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degeneration |
| US20230293598A1 (en) * | 2022-03-15 | 2023-09-21 | Narkeshyo LLC | Prevention of radiation exposure associated pathology by treatment with umbilical cord derived regenerative cells |
| US20240003871A1 (en) * | 2022-06-29 | 2024-01-04 | FUJIFILM Cellular Dynamics, Inc. | Ipsc-derived astrocytes and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| EP1082410B1 (en) | 1998-05-29 | 2007-08-01 | Osiris Therapeutics, Inc. | Human cd45+ and/or fibroblast + mesenchymal stem cells |
| US20030161818A1 (en) | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
| JP4790592B2 (ja) | 2003-02-11 | 2011-10-12 | ダビース，ジヨン・イー | ヒト臍帯のウォートンジェリーからの前駆細胞 |
| CA2530421C (en) | 2003-06-27 | 2015-04-21 | Ethicon, Incorporated | Repair and regeneration of ocular tissue using postpartum-derived cells |
| NZ553695A (en) * | 2004-08-16 | 2009-10-30 | Cellres Corp Pte Ltd | Isolation of stem/progenitor cells from amniotic membrane of umbilical cord |
| WO2007106089A1 (en) | 2006-03-14 | 2007-09-20 | Spherical Dynamics, Inc. | System for and method for psychological assessment |
| HRP20130765T1 (hr) * | 2007-02-12 | 2013-10-25 | Anthrogenesis Corporation | Lijeäśenje protuupalnih bolesti putem matiäśnih stanica posteljice |
| PT103843B (pt) | 2007-10-04 | 2008-08-12 | Medinfar Produtos Farmaceutico | Método de isolamento de células precursoras a partir do cordão umbilical humano |
| WO2010060031A1 (en) * | 2008-11-21 | 2010-05-27 | Anthrogenesis Corporation | Treatment of diseases, disorders or conditions of the lung using placental cells |
| CN101748096B (zh) * | 2008-12-17 | 2013-03-13 | 北京汉氏联合生物技术有限公司 | 亚全能干细胞、其制备方法及其用途 |
| CA2756670A1 (en) | 2009-03-26 | 2010-09-30 | The Regents Of The University Of California | Mesenchymal stem cells producing inhibitory rna for disease modification |
| IN2012DN02532A (enExample) * | 2009-09-23 | 2015-08-28 | Davinci Bioscineces Llc | |
| CN101890050B (zh) * | 2010-07-14 | 2012-07-04 | 江苏大学 | 脐带间质干细胞来源膜性囊泡及其应用 |
| EP2540819A1 (en) | 2011-06-27 | 2013-01-02 | Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) | Method for cultivating cells in platelet-lysate-containing medium |
| US20210355437A1 (en) | 2015-09-02 | 2021-11-18 | Restem Llc | Factor rich product from umbilical cord mesenchymal stem cells |
-
2012
- 2012-12-31 ES ES17191442T patent/ES2890126T3/es active Active
- 2012-12-31 CA CA3113484A patent/CA3113484A1/en active Pending
- 2012-12-31 PT PT171914427T patent/PT3321355T/pt unknown
- 2012-12-31 PL PL17191442T patent/PL3321355T3/pl unknown
- 2012-12-31 EP EP12862921.9A patent/EP2798058B1/en active Active
- 2012-12-31 EP EP17191442.7A patent/EP3321355B1/en active Active
- 2012-12-31 HU HUE17191442A patent/HUE056817T2/hu unknown
- 2012-12-31 WO PCT/US2012/072331 patent/WO2013102219A1/en not_active Ceased
- 2012-12-31 DK DK17191442.7T patent/DK3321355T3/da active
- 2012-12-31 ES ES12862921.9T patent/ES2656614T3/es active Active
- 2012-12-31 SI SI201231950T patent/SI3321355T1/sl unknown
- 2012-12-31 US US13/732,204 patent/US9803176B2/en active Active
- 2012-12-31 JP JP2014550544A patent/JP6548897B2/ja active Active
- 2012-12-31 CA CA2862661A patent/CA2862661C/en active Active
-
2017
- 2017-10-31 US US15/799,743 patent/US20190218519A1/en not_active Abandoned
-
2021
- 2021-05-17 US US17/322,672 patent/US20220041992A1/en not_active Abandoned
- 2021-08-30 HR HRP20211373TT patent/HRP20211373T1/hr unknown
- 2021-12-22 US US17/559,545 patent/US20220251514A1/en not_active Abandoned
- 2021-12-22 US US17/559,539 patent/US20220251513A1/en not_active Abandoned
- 2021-12-22 US US17/559,583 patent/US12441986B2/en active Active
-
2025
- 2025-04-02 US US19/098,979 patent/US20250346865A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015503918A5 (enExample) | ||
| MY177970A (en) | Bcma (cd269/tnfrsf17) -binding proteins | |
| BR112013012555A2 (pt) | peptídeos imunogênicos para o uso na prevenção e/ou no tratamento de doenças infecciosas, doenças autoimunes, respostas imunes a alofatores, doenças alérgicas, tumores, rejeição a enxertos e respostas imunes contra vetores virais usados para a terapia de genes ou na vacinação de genes | |
| IL255752B (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer | |
| CY1121310T1 (el) | Χρηση πυριτικου ζιρκονιου για τη θεραπεια της υπερκαλιαιμιας | |
| UA100682C2 (ru) | АНТИТЕЛО, КОТОРОЕ НЕЙТРАЛИЗУЕТ ЧЕЛОВЕЧЕСКИЙ ЦИТОМЕГАЛОВИРУС (hCMV), И ЕГО ПРИМЕНЕНИЕ | |
| JP2013517798A5 (enExample) | ||
| EA201270713A1 (ru) | Белки на основе фибронектина с каркасными доменами, которые связывают ил-23 | |
| DOP2006000162A (es) | Nuevos anticuerpos anti-madcan | |
| WO2013185112A8 (en) | Pharmaceutical compositions for the treatment of cftr -mediated disorders | |
| EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| EA201201661A1 (ru) | Новые аминопиразолохиназолины | |
| MX2010003574A (es) | Anticuerpos il-23. | |
| UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
| EA201390682A1 (ru) | Спирооксиндольные антагонисты mdm2 | |
| EA201000897A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
| BRPI1014718A2 (pt) | polipeptídeo do papiloma vírus humano, capsômero, partícula tipo vírus, composição imunogência, molécula de ácido nucléico, e, métodos para produzir o polipeptídeo, e, para preparar uma composição imunogênica | |
| EA201170659A1 (ru) | Антитела к рецептору ii tgf-вета | |
| IN2015DN02729A (enExample) | ||
| JO3547B1 (ar) | أجسام مضادة ضد تخليق جدار الخلية واستعمالاتها | |
| WO2012083302A3 (en) | Compositions and methods for the treatment or prevention of human adenovirus-36 infection | |
| AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
| BR112014011981A2 (pt) | formulações farmacêuticas | |
| IT1405793B1 (it) | Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica | |
| EP2187898B8 (en) | Use of viral vectors carrying the cyp46a1 gene for the treatment of alzheimer's disease |